Illegal ayurvedic medicine factory busted in Valsad, raw materials, machinery seized

Valsad:  A factory manufacturing Ayurvedic medicines illegally has been busted behind the Vishwambhari temple in Rabda, Valsad district of Gujarat. Food and Drug Administration (FDA) officials have raided the factory and taken massive action.

During the raid, the FDA has found a large quantity of various types of Ayurvedic medicines, such as powder, pills, tablets, extracts, soaps and oils. In addition, raw materials and machinery used to make the medicine have also been seized.
Preliminary investigation has revealed that this factory was running without any proper permission. This factory was manufacturing medicines illegally in violation of the guidelines of the Food and Drug Department.

Samples of the seized medicines have been sent to the laboratory so that their quality and safety can be assessed. Further legal action will be taken after receiving the laboratory report.

This incident has raised concerns about illegal Ayurvedic medicine manufacturing in Gujarat. FDA is continuously monitoring such illegal activities and strict action will be taken.

Related Posts

Licences of 20 medical stores suspended after inspections

Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket